Corporate Finance Staff Learn Tax Knowledge
Release time:
2020-08-14
Company Finance Staff Learn Tax Knowledge
News Facing the major adjustment of tax policy, the new tax assessment index system has been put into use and the third phase of the Golden Tax Project has been fully rolled out. 11# August 23 , some financial personnel of the group participated in the training meeting of Jinhua Zhongrui office on "on 2017 enterprise income tax settlement and year-end tax risk control. The
meeting interpreted the policies of enterprise income tax, value-added tax, personal income tax and local taxes and fees, the pre-tax deduction of research and development expenses of small and medium-sized technology-based enterprises and the follow-up management policies of high-tech enterprises, the tax policy of replacing business tax with value-added tax has been improved one after another, the new policy of deduction of agricultural and sideline products, the operating procedures of VAT tax declaration and comparison management, and new guidelines of government subsidies, etc. In particular, relevant work has been arranged before the end of the year, and emphasis has been placed on the effective implementation of tax risk monitoring and analysis and strengthening of tax risk management through desk review, timely comparison of third-party information with tax declaration information, and use of tax analysis software under the management of the golden tax phase III big data model. With the revision of the Accounting Law, it will create a better environment for fiscal and taxation practitioners to abide by their ethics. (Zhou Ying)
Knowledge Link:
What is the "Golden Tax Project"
In order to effectively prevent criminals from stealing, defrauding and evading state taxes by means of forgery, reselling, theft and false issuance of special invoices, the state has decided to introduce modern technical means to strengthen VAT collection management on the basis of physical anti-counterfeiting of paper special invoices. In 1994 , the relevant departments of the state began to build the "Golden Tax Project" with the main goal of strengthening the management of value-added tax ".
The overall goal of the Golden Tax Project is to establish "one platform, two levels of processing, three overlays, and four systems". According to the principle of integration, establish a unified and standardized application system platform, relying on computer networks, the General Administration and provincial bureaus highly centralize information processing, covering all taxes, all work links, the State and Local Taxation Bureau and networking with relevant departments, including collection and management business, administrative management, A tax management information system with complete functions, coordination and efficiency, information sharing, strict monitoring, safety and stability, and strong guarantee.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page